EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Assessment of the impact of the new blister packaging of Biktarvy® (B/F/TAF) on treatment satisfaction of people living with HIV

João Paulo Cruz, Osvaldo Santos, Marisa Rodrigues, Raquel Morais, Teresa Borralho, Filipa Ferreira, Abigail Ferreira iD, João Albuquerque, Paulo Nogueira, Maria Pinto da Silva iD, Francisco Antunes iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0313458 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift PLOS One, 2025. Verfasst von João Paulo Cruz und 10 weiteren Autor:innen. Beteiligte Einrichtung: Serviços Farmacêuticos da Unidade de Saúde Local Santa Maria, Lisboa, Portugal. Hauptthemen laut MEDLINE: HIV Infections, Patient Satisfaction, Drug Packaging, Anti-HIV Agents. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gilead Sciences Inc..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Antiretroviral therapy (ART) is highly effective in people living with HIV (PLHIV), but its success depends on treatment satisfaction and adherence. A determinant of satisfaction regards how the medication is delivered to the patient, namely how it is contained (e.g., bottles, blisters, etc). A new packaging of Biktarvy ® has been introduced as a monthly blister, aiming to improve satisfaction, facilitate traceability of daily medication, portability, and discretion (reducing stigma associated with ART), and, ultimately, enhance adherence. Goals The study’s objective was to assess the impact of changing the packaging of Biktarvy® (B/F/TAF) from a standard pill bottle to a monthly blister with a weekly calendar on therapy satisfaction. Additionally, the association between treatment satisfaction and selected patients’ characteristics (e.g., ART duration) was evaluated. A secondary goal was to characterize the association between the change of packaging on patient’s adherence.

Methods

This is an observational longitudinal (retrospective and prospective) study with patients following ART for at least six months (ambulatory clinical management) recruited according to a non-probabilistic sequential sampling. Satisfaction was measured at two different moments: at baseline, HIVTSQs were used to assess satisfaction within the previous six months’ use of medication containers (bottles). Six months later, patients filled in the HIVTSQc to assess their perception of satisfaction change with the new packaging (blister). Adherence was assessed by pharmacy medication dispensing at the hospital.

Results

The study enrolled 105 patients in two selected centers (102 patients completed the study). Patients were significantly more satisfied (HIVTSQc scores) with ART when using the new Biktarvy® blister pack package. Importantly, gains of ART satisfaction were higher among those less satisfied with the bottle packaging. No significant associations were found between HIVTSQc scores and sociodemographic or ART-related variables.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsPatient SatisfactionDrug PackagingAnti-HIV AgentsHumansMaleFemaleMiddle AgedAdultProspective StudiesRetrospective StudiesLongitudinal StudiesMedication Adherence

Substanzen

Anti-HIV Agents

Autor:innen und Institutionen

  • Serviços Farmacêuticos da Unidade de Saúde Local Santa Maria, Lisboa, Portugal.
  • iMed.ULisboa - Institute for Medicine Research, Faculdade de Farmácia, Universidade de Lisboa, Lisboa, Portugal.
  • Instituto de Saúde Ambiental, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.
  • Unbreakable Idea Research, Painho, Portugal.
  • BlueClinical - Investigação e Desenvolvimento em Saúde, Lda, Porto, Portugal.
  • Centro de Estatística e Aplicações, Faculdade de Ciências, Universidade de Lisboa, Lisboa, Portugal.

ORCID-Profile: Abigail Ferreira, Maria Pinto da Silva, Francisco Antunes

Förderung

  • Gilead Sciences Inc.

Zitieren

APA

Cruz, J. P., Santos, O., Rodrigues, M., Morais, R., Borralho, T., Ferreira, F., Ferreira, A., Albuquerque, J., Nogueira, P., Pinto da Silva, M., & Antunes, F. (2025). Assessment of the impact of the new blister packaging of Biktarvy® (B/F/TAF) on treatment satisfaction of people living with HIV. PLOS One. https://doi.org/10.1371/journal.pone.0313458

Vancouver

Cruz JP, Santos O, Rodrigues M, Morais R, Borralho T, Ferreira F, et al. Assessment of the impact of the new blister packaging of Biktarvy® (B/F/TAF) on treatment satisfaction of people living with HIV. PLOS One. 2025. doi:10.1371/journal.pone.0313458

BibTeX
@article{Cruz2025,
  author = {Cruz, João Paulo and Santos, Osvaldo and Rodrigues, Marisa and Morais, Raquel and Borralho, Teresa and Ferreira, Filipa and Ferreira, Abigail and Albuquerque, João and Nogueira, Paulo and Pinto da Silva, Maria and Antunes, Francisco},
  title = {Assessment of the impact of the new blister packaging of Biktarvy® (B/F/TAF) on treatment satisfaction of people living with HIV},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0313458}
}
Kostenlos starten →